Gastro-Esophageal Junction Precancerosis: Histological Diagnostic Approach and Pathogenetic Insights.

Simple Summary: A diagnosis of Barrett's esophagus (BE) requires the macroscopic visualization of gastric-appearing mucosa in the esophagus and the identification of intestinal metaplasia on histologic examination. Histologic diagnosis of BE dysplasia can be challenging due to sampling error, pathol...

Descripción completa

Detalles Bibliográficos
Publicado en:Cancers Vol. 15; no. 24; pp. 5725 - 5738
Autores principales: Giacometti, Cinzia, Gusella, Anna, Cassaro, Mauro
Formato: pictorial review tables/charts Journal Article
Publicado: MDPI Dec2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=174403375&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 174403375
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20726694
        B74B
      jtl: Cancers
      issn: 20726694
      maglogo: N
    pubinfo:
      dt: Dec2023
      vid: 15
      iid: 24
      pid: 97109
      pub: MDPI
    artinfo:
      ui:
        174403375
        174403375
        174403375
        10.3390/cancers15245725
        174403375
      ppf: 5725
      ppct: 13
      formats:
      tig:
        atl: Gastro-Esophageal Junction Precancerosis: Histological Diagnostic Approach and Pathogenetic Insights.
      aug:
        au:
          Giacometti, Cinzia
          Gusella, Anna
          Cassaro, Mauro
        affil: Pathology Unit, Department of Diagnostic Services, ULSS 6 Euganea, 35131 Padova, Italy
      sug:
        subj:
          Barrett Esophagus Diagnosis
          Practice Guidelines
          Barrett Esophagus Risk Factors
          Pathology, Molecular
          Barrett Esophagus Physiopathology
          Gastric Mucosa Analysis
          Metaplasia Diagnosis
          Esophagus Pathology
          Gastroesophageal Reflux Complications
          Adenocarcinoma Risk Factors
          Esophageal Neoplasms Risk Factors
          Inflammation Pathology
          Epithelial Cells Physiopathology
          Genetics
          Epigenomics
          Pathologic Processes Risk Factors
          Histology
          Severity of Illness
          Pathologists
          Work Experiences
          Sampling Error
          Genes Evaluation
          Cell Cycle Evaluation
          Signal Transduction Evaluation
          Apoptosis Evaluation
          Genomics
      ab: Simple Summary: A diagnosis of Barrett's esophagus (BE) requires the macroscopic visualization of gastric-appearing mucosa in the esophagus and the identification of intestinal metaplasia on histologic examination. Histologic diagnosis of BE dysplasia can be challenging due to sampling error, pathologists' experience, interobserver variation, and difficulty in histologic interpretation: all these problems complicate patient management. In intestinal metaplasia, which occurs because of chronic gastresophageal reflux disease (GERD), the squamous epithelium converts to columnar epithelium, which is initially of the cardia type and devoid of goblet cells; it later develops goblet cell metaplasia and eventually dysplasia, which develops and progresses to adenocarcinoma because of the accumulation of multiple genetic and epigenetic alterations. Therefore, this review aims to provide an up-to-date and clear diagnostic approach to Barrett's esophagus and an overview of dysplasia's development's pathogenetic and molecular mechanisms. Barrett's esophagus (BE) was initially defined in the 1950s as the visualization of gastric-like mucosa in the esophagus. Over time, the definition has evolved to include the identification of goblet cells, which confirm the presence of intestinal metaplasia within the esophagus. Chronic gastro-esophageal reflux disease (GERD) is a significant risk factor for adenocarcinoma of the esophagus, as intestinal metaplasia can develop due to GERD. The development of adenocarcinomas related to BE progresses in sequence from inflammation to metaplasia, dysplasia, and ultimately carcinoma. In the presence of GERD, the squamous epithelium changes to columnar epithelium, which initially lacks goblet cells, but later develops goblet cell metaplasia and eventually dysplasia. The accumulation of multiple genetic and epigenetic alterations leads to the development and progression of dysplasia. The diagnosis of BE requires the identification of intestinal metaplasia on histologic examination, which has thus become an essential tool both in the diagnosis and in the assessment of dysplasia's presence and degree. The histologic diagnosis of BE dysplasia can be challenging due to sampling error, pathologists' experience, interobserver variation, and difficulty in histologic interpretation: all these problems complicate patient management. The development and progression of Barrett's esophagus (BE) depend on various molecular events that involve changes in cell-cycle regulatory genes, apoptosis, cell signaling, and adhesion pathways. In advanced stages, there are widespread genomic abnormalities with losses and gains in chromosome function, and DNA instability. This review aims to provide an updated and comprehensible diagnostic approach to BE based on the most recent guidelines available in the literature, and an overview of the pathogenetic and molecular mechanisms of its development.
      pubtype: Academic Journal
      doctype:
        pictorial
        review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N